Cardiology/Vascular Diseases
- Azor (amlodipine besylate; olmesartan medoxomil); For the treatment of hypertension; Daiichi Sankyo; Approved September 2007
- Fenofibrate; For the treatment of hyperlipidemia, dyslipidemia and hypertriglyceridemia; LifeCycle Pharma; Approved August 2007
- Letairis (ambrisentan); For the treatment of pulmonary arterial hypertension; Gilead; Approved June 2007
- Soliris (eculizumab); For the treatment of paroxysmal nocturnal hemoglobinuria; Alexion Pharm; Approved March 2007
- Tekturna (aliskiren); For the treatment of hypertension; Novartis Pharms; Approved March 2007
No comments:
Post a Comment